Search research articles
Contact Us
Filters
Showing results (61-70 of 95) with videos related to
Page
of 10
Sort By:
Pharmacogenetics
|
April 20, 1999
The stereoselective metabolism of fluoxetine in poor and extensive metabolizers of sparteine
L Fjordside, U Jeppesen, C B Eap, et al.
Clinical Pharmacology and Therapeutics
|
May 20, 2011
Impact of smoking, smoking cessation, and genetic polymorphisms on CYP1A2 activity and inducibility
M Dobrinas, J Cornuz, B Oneda, et al.
Journal of Chromatography. B, Biomedical Applications
|
March 29, 1996
Two-step chromatographic purification of human plasma alpha(1)-acid glycoprotein: its application to the purification of rare phenotype samples of the protein and their study by chromatography on immobilized metal chelate affinity adsorbent
F Herve, M C Millot, C B Eap, et al.
AIDS (London, England)
|
July 14, 2000
Efavirenz decreases methadone blood concentrations
C Marzolini, N Troillet, A Telenti, et al.
Therapeutic Drug Monitoring
|
March 5, 1998
Steady state concentrations of the enantiomers of mianserin and desmethylmianserin in poor and in homozygous and heterozygous extensive metabolizers of debrisoquine
C B Eap, C A Lima, F Macciardi, et al.
Pharmacopsychiatry
|
March 22, 2003
Clinical outcome after trimipramine in patients with delusional depression - a pilot study
R-M Frieboes, A Sonntag, A Yassouridis, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
April 29, 2004
Determination of human plasma levels of levo-alpha-acetylmethadol and its metabolites by gas chromatography-mass spectrometry
C B Eap, G Bouchoux, N Scherbaum, et al.
Journal of Clinical Pharmacy and Therapeutics
|
November 21, 2007
Pharmacogenetics of acenocoumarol: CYP2C9, CYP2C19, CYP1A2, CYP3A4, CYP3A5 and ABCB1 gene polymorphisms and dose requirements
R B Saraeva, I D Paskaleva, E Doncheva, et al.
Neuropsychobiology
|
January 1, 1992
Influence of quinidine on the pharmacokinetics of trimipramine and on its effect on the waking EEG of healthy volunteers. A pilot study on two subjects
C B Eap, S Laurian, A Souche, et al.
Journal of Chromatography
|
July 2, 1993
Determination of plasma levels of citalopram and its demethylated and deaminated metabolites by gas chromatography and gas chromatography-mass spectrometry
P Reymond, M Amey, A Souche, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 95) with videos related to
Sort By:
Page
of 10
Pharmacogenetics
|
April 20, 1999
The stereoselective metabolism of fluoxetine in poor and extensive metabolizers of sparteine
L Fjordside, U Jeppesen, C B Eap, et al.
Clinical Pharmacology and Therapeutics
|
May 20, 2011
Impact of smoking, smoking cessation, and genetic polymorphisms on CYP1A2 activity and inducibility
M Dobrinas, J Cornuz, B Oneda, et al.
Journal of Chromatography. B, Biomedical Applications
|
March 29, 1996
Two-step chromatographic purification of human plasma alpha(1)-acid glycoprotein: its application to the purification of rare phenotype samples of the protein and their study by chromatography on immobilized metal chelate affinity adsorbent
F Herve, M C Millot, C B Eap, et al.
AIDS (London, England)
|
July 14, 2000
Efavirenz decreases methadone blood concentrations
C Marzolini, N Troillet, A Telenti, et al.
Therapeutic Drug Monitoring
|
March 5, 1998
Steady state concentrations of the enantiomers of mianserin and desmethylmianserin in poor and in homozygous and heterozygous extensive metabolizers of debrisoquine
C B Eap, C A Lima, F Macciardi, et al.
Pharmacopsychiatry
|
March 22, 2003
Clinical outcome after trimipramine in patients with delusional depression - a pilot study
R-M Frieboes, A Sonntag, A Yassouridis, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
April 29, 2004
Determination of human plasma levels of levo-alpha-acetylmethadol and its metabolites by gas chromatography-mass spectrometry
C B Eap, G Bouchoux, N Scherbaum, et al.
Journal of Clinical Pharmacy and Therapeutics
|
November 21, 2007
Pharmacogenetics of acenocoumarol: CYP2C9, CYP2C19, CYP1A2, CYP3A4, CYP3A5 and ABCB1 gene polymorphisms and dose requirements
R B Saraeva, I D Paskaleva, E Doncheva, et al.
Neuropsychobiology
|
January 1, 1992
Influence of quinidine on the pharmacokinetics of trimipramine and on its effect on the waking EEG of healthy volunteers. A pilot study on two subjects
C B Eap, S Laurian, A Souche, et al.
Journal of Chromatography
|
July 2, 1993
Determination of plasma levels of citalopram and its demethylated and deaminated metabolites by gas chromatography and gas chromatography-mass spectrometry
P Reymond, M Amey, A Souche, et al.
Page
of 10